Dec 17, 2020
WASHINGTON, D.C. A bipartisan congressional investigation released Wednesday found that key players in the nation’s opioid industry have spent $65 million since 1997 funding nonprofits that advocate treating pain with medications, a strategy intended to boost the sale of prescription painkillers.
The report from Sens. Chuck Grassley of Iowa and Ron Wyden of Oregon found the contributions continued in recent years, even as the industry’s practices and the toll of opioid addiction came under greater scrutiny.
The senators, the top Republican and Democrat on the Senate Finance Committee, are considering legislation to expand an existing federal system that tracks payments from companies to doctors so it will include payments to nonprofit organizations.
United-states
Oregon
Washington
Iowa
American
Ron-wyden
Kimberly-wix
Daiichi-sankyo
Chuck-grassley
Alliance-for-balanced-pain-management
Purdue-pharma
Senate-finance-committee
Associated Press
A bipartisan congressional investigation released Wednesday found that key players in the nation’s opioid industry have spent $65 million since 1997 funding nonprofits that advocate treating pain with medications, a strategy intended to boost the sale of prescription painkillers.
The report from Sens. Chuck Grassley of Iowa and Ron Wyden of Oregon found the contributions continued in recent years, even as the industry’s practices and the toll of opioid addiction came under greater scrutiny.
The senators, the top Republican and Democrat on the Senate Finance Committee, are considering legislation to expand an existing federal system that tracks payments from companies to doctors so it will include payments to nonprofit organizations.
United-states
Oregon
Iowa
American
Ron-wyden
Daiichi-sankyo
Chuck-grassley
Alliance-for-balanced-pain-management
Purdue-pharma
Senate-finance-committee
Us-department-of-health
Human-services